temp_copy

by Tabitha Moses  Tabitha Moses, M.S., is Administrative and Research Coordinator at Lehman College, CUNY, as well as a Research Affiliate at the National Core for Neuroethics at the University of British Columbia. Tabitha earned her BA in Cognitive Science and Philosophy and MS in Biotechnology from The Johns Hopkins University. She has conducted research in the areas of addiction, mental illness, and emerging neurotechnologies. She hopes to continue her education through a joint MD/PhD in Neuroscience while maintaining a focus on neuroethics. The introduction of “addiction vaccines” has brought with it a belief that we have the potential to cure addicts before they have ever even tried a drug. Proponents of addiction vaccines hold that they will: prevent children from becoming addicted to drugs in the future,  allow addicts to easily and safely stop using drugs, and  potentially lower the social and economic costs of addiction for society at large. However, it is cri...

Imagine a vaccine that causes our immune system to create antibodies against a drug like cocaine. After being vaccinated, we could snort cocaine and the antibodies would sequester the drug before it could reach our brain. A recent article in Nature Immunology’s Commentary section, “Immune to Addiction” , considers the ethical implications of such vaccines. We discussed the article at December's meeting of the Neuroethics Journal Club, led by Emory Neuroscience graduate student, Jordan Kohn. Jordan Kohn: his provocative Powerpoint for journal club momentarily made me think I was an anti-vaxxer Here's what I took away from this month's meeting: we need to integrate the different ways we study addiction. You might wonder what the ways we study substance abuse have to do with a vaccine against it. As the authors of the article say, "How substance dependence is characterized and classified informs the appropriateness of strategies aimed" at preventing or treating it. I...